FI922459A - Foerfarande foer framstaellning av substituerade diaminoftalimider och deras analoger - Google Patents

Foerfarande foer framstaellning av substituerade diaminoftalimider och deras analoger Download PDF

Info

Publication number
FI922459A
FI922459A FI922459A FI922459A FI922459A FI 922459 A FI922459 A FI 922459A FI 922459 A FI922459 A FI 922459A FI 922459 A FI922459 A FI 922459A FI 922459 A FI922459 A FI 922459A
Authority
FI
Finland
Prior art keywords
framework
diaminoftalimider
analoger
deras
substitutes
Prior art date
Application number
FI922459A
Other languages
English (en)
Other versions
FI100530B (fi
FI922459A0 (fi
Inventor
Uwe Trinks
Peter Traxler
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI922459A0 publication Critical patent/FI922459A0/fi
Publication of FI922459A publication Critical patent/FI922459A/fi
Priority to FI970980A priority Critical patent/FI970980A0/fi
Application granted granted Critical
Publication of FI100530B publication Critical patent/FI100530B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Indole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Stringed Musical Instruments (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Pyridine Compounds (AREA)
FI922459A 1991-05-30 1992-05-27 Menetelmä substituoitujen diaminoftaali-imidien ja niiden analogien va lmistamiseksi FI100530B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI970980A FI970980A0 (fi) 1991-05-30 1997-03-07 Substituoidut diaminoftaali-imidit ja niiden analogit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH160191 1991-05-30
CH160191 1991-05-30

Publications (3)

Publication Number Publication Date
FI922459A0 FI922459A0 (fi) 1992-05-27
FI922459A true FI922459A (fi) 1992-12-01
FI100530B FI100530B (fi) 1997-12-31

Family

ID=4214234

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922459A FI100530B (fi) 1991-05-30 1992-05-27 Menetelmä substituoitujen diaminoftaali-imidien ja niiden analogien va lmistamiseksi

Country Status (25)

Country Link
EP (1) EP0516588B1 (fi)
JP (1) JP2593273B2 (fi)
KR (1) KR920021508A (fi)
CN (1) CN1067052A (fi)
AT (1) ATE108437T1 (fi)
AU (1) AU653024B2 (fi)
CA (1) CA2069857A1 (fi)
CS (1) CS156792A3 (fi)
CY (1) CY1979A (fi)
DE (1) DE59200277D1 (fi)
DK (1) DK0516588T3 (fi)
ES (1) ES2056699T3 (fi)
FI (1) FI100530B (fi)
HK (1) HK214896A (fi)
HU (1) HUT66655A (fi)
IE (1) IE65772B1 (fi)
IL (1) IL102038A0 (fi)
MA (1) MA22540A1 (fi)
MX (1) MX9202544A (fi)
NO (1) NO178261C (fi)
NZ (1) NZ242941A (fi)
PL (1) PL170909B1 (fi)
RU (1) RU2095349C1 (fi)
TW (1) TW204341B (fi)
ZA (1) ZA923940B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491144A (en) * 1991-05-30 1996-02-13 Ciba-Geigy Corporation Substituted diaminophthalimides and analogues
EP0600830A1 (de) * 1992-11-27 1994-06-08 Ciba-Geigy Ag Substituierte Derivate von Diaminophthalimid als Protein-Tyrosin-Kinase-Hemmer
EP0600831A1 (de) * 1992-11-27 1994-06-08 Ciba-Geigy Ag Phthalazinonderivate
WO1995000157A1 (en) * 1993-06-25 1995-01-05 Mobius Consultancy Pty. Ltd. Therapeutic agent
AU691815B2 (en) * 1993-06-25 1998-05-28 Main Camp Marketing Pty. Ltd. Therapeutic agent
GB9314893D0 (en) * 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives
GB9325217D0 (en) * 1993-12-09 1994-02-09 Zeneca Ltd Pyrimidine derivatives
WO1995024190A2 (en) * 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
GB9600545D0 (en) 1996-01-11 1996-03-13 Ciba Geigy Ag Compositions
EP1661566A3 (en) * 1996-08-05 2008-04-16 Myriad Genetics, Inc. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
DE69735545T2 (de) * 1996-08-05 2006-08-10 Myriad Genetics, Inc., Salt Lake City Verwendung von beta-blatt mimetika als protease und kinase hemmer und alshemmer eines transkriptionsfaktors
KR100840635B1 (ko) * 2001-11-30 2008-06-24 와코 쥰야꾸 고교 가부시키가이샤 비스이미드 화합물, 이것을 이용한 산 발생제 및 레지스트조성물 및 해당 조성물을 이용한 패턴 형성 방법
WO2005039564A1 (en) * 2003-10-02 2005-05-06 Vertex Pharmaceuticals Incorporated Phthalimide compounds useful as protein kinase inhibitors
WO2006047514A2 (en) * 2004-10-25 2006-05-04 Whitehead Institute For Biomedical Research Daph analogs and inhibition of protein aggregation
US7745641B2 (en) 2005-04-19 2010-06-29 Kyowa Hakko Kirin Co., Ltd. Nitrogen-containing heterocyclic compound
DE102009031058A1 (de) * 2009-06-30 2011-01-27 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Amiden aromatischer Carbonsäuren
JP5934559B2 (ja) * 2012-04-05 2016-06-15 国立大学法人京都工芸繊維大学 発光材料および有機ｅｌ素子
CN105434432B (zh) * 2015-12-04 2018-11-13 中国科学院昆明植物研究所 N-羟基邻苯二甲酰亚胺类化合物在制备抗肿瘤药物中的应用
EP4367112A1 (en) 2021-07-09 2024-05-15 Plexium, Inc. Aryl compounds and pharmaceutical compositions that modulate ikzf2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857947A (en) * 1972-08-14 1974-12-31 Stauffer Chemical Co Fungicidal active phthalimides
GB1581073A (en) * 1976-09-08 1980-12-10 Campbell Chain Co Locking assembly
JPS60161968A (ja) * 1984-01-31 1985-08-23 Sankyo Co Ltd フタ−ルイミド誘導体及び農業用殺菌剤

Also Published As

Publication number Publication date
FI100530B (fi) 1997-12-31
RU2095349C1 (ru) 1997-11-10
HU9201789D0 (en) 1992-08-28
IE921770A1 (en) 1992-12-02
PL170909B1 (pl) 1997-02-28
CY1979A (en) 1997-09-05
AU1705392A (en) 1992-12-03
MA22540A1 (fr) 1992-12-31
NO922133D0 (no) 1992-05-29
EP0516588A1 (de) 1992-12-02
CA2069857A1 (en) 1992-12-01
JPH05163240A (ja) 1993-06-29
DE59200277D1 (de) 1994-08-18
JP2593273B2 (ja) 1997-03-26
IL102038A0 (en) 1992-12-30
NZ242941A (en) 1994-10-26
AU653024B2 (en) 1994-09-15
NO178261C (no) 1996-02-21
NO922133L (no) 1992-12-01
PL294701A1 (fi) 1993-02-08
FI922459A0 (fi) 1992-05-27
IE65772B1 (en) 1995-11-15
CS156792A3 (en) 1992-12-16
HK214896A (en) 1996-12-13
MX9202544A (es) 1992-11-01
CN1067052A (zh) 1992-12-16
EP0516588B1 (de) 1994-07-13
ZA923940B (en) 1993-11-15
ATE108437T1 (de) 1994-07-15
HUT66655A (en) 1994-12-28
NO178261B (no) 1995-11-13
TW204341B (fi) 1993-04-21
DK0516588T3 (da) 1994-08-15
KR920021508A (ko) 1992-12-18
ES2056699T3 (es) 1994-10-01

Similar Documents

Publication Publication Date Title
FI922459A (fi) Foerfarande foer framstaellning av substituerade diaminoftalimider och deras analoger
NO921835D0 (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
FI921030A0 (fi) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE59203976D1 (de) Hydantoinderivate.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
FI891361A0 (fi) Menetelmä farmaseuttisesti vaikuttavien aryylihydratsonien valmistamiseksi
DE59002783D1 (de) Diphenylheteroalkylderivate, ihre Herstellung und daraus hergestellte Arzneimittel und Kosmetika.
ATE110365T1 (de) 2-alkyl-4-arylmethylaminochinoline, ihre verwendung und daraus hergestellte arzneimittel.
FI960658A (fi) Uudet bis-naftalimidit syövän hoitamiseksi
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
ES2104682T3 (es) Fluor-compuestos.
FI852743L (fi) Acetyleniska fenoxipropanolderivat och farmaceutiska kompositioner foer behandling av hypertoni.
ES2098338T3 (es) Heteroarilmetilbencenos.
YU61096A (sh) Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
FI912269A0 (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
ATE155479T1 (de) Neue cytarabin-derivate, ihre herstellung und verwendung

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

MM Patent lapsed